Terms ending in 2036
Every in-force patent on Sandoz AG's record whose computed term ends in 2036, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 10,159,661 | Penicillin Retard Composition For Intramuscular Injection In force · High confidence | Sandoz AG | In force | High confidence | |
| US 10,053,427 | Crystalline Forms of Cabozantinib Phosphate And Cabozantinib Hydrochloride In force · High confidence | Sandoz AG | In force | High confidence | |
| US 10,206,916 | Cabozantinib Salts And Their Use As Anti-Cancer Agents In force · High confidence | Sandoz AG | In force | High confidence | |
| US 10,711,276 | Sequence Variants In force · High confidence | Sandoz AG | In force | High confidence | |
| US 10,265,326 | Form C of Avibactam Sodium In force · High confidence | Sandoz AG | In force | High confidence | |
| US 10,919,893 | Process for the Preparation of Crystalline Form C of Avibactam Sodium In force · High confidence | Sandoz AG | In force | High confidence | |
| US D928,939 | Injection Device In force · High confidence | Novartis AG | In force | High confidence | |
| US D928,940 | Injection Device In force · High confidence | Novartis AG | In force | High confidence | |
| US D928,941 | Injection Device In force · High confidence | Novartis AG | In force | High confidence | |
| US D928,942 | Injection Device In force · High confidence | Novartis AG | In force | High confidence | |
| 1 more term end in 2036 · Pro | |||||
10 of 11 patents shown. Soonest term end first, then patent number.
Pro members see all 11.
6 of these are in force and held by Sandoz AG.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.